The setup heading into MaxLinear's October 22 print is mixed-to-cautious: the stock has shed roughly 30% from its early-October peak of $113.13 in just seven sessions, yet options-flow accumulation and a sharp upward revision cycle argue that the fundamental story remains intact. The question is whether a relief rally off earnings can override what has been unusually brutal near-term price action.
The Setup: A Stock in Freefall Before the Print
MaxLinear (NASDAQ: MXL) closed at $78.82 on October 14, down 11.1% in that session alone after opening near $84.50. The five-day trend is firmly DOWN (–15.9%), and the 100-day trend is similarly soft, registering a –20.5% price change on a sideways, weak-momentum reading with the stock sitting below its statistical mean — a bearish positioning signal on the longer timeframe.
The recent price history tells the story starkly. MXL surged to $113.13 on October 7 following a Topaz AI Gateway unveiling at Network X 2026 — only to give back nearly every penny of those gains within a week. The 20-day trend is still technically positive (+5.1%), supported by a base near $78.15, which also marks the September 17 closing low of $72.39 providing the deeper floor. The RSI sits at 44.1, not yet oversold, and the 20-day simple moving average is well above at $91.69 — a level MXL would need to reclaim to signal a genuine recovery.
What drove the collapse matters for interpreting the earnings setup. The sell-off coincided with sector-wide pressure on connectivity semis (peers like Credo Technology and Astera Labs both fell sharply in the same window), suggesting macro rotation rather than a company-specific implosion. MaxLinear's Topaz platform and MaxAI broadband intelligence initiative received positive industry coverage as recently as October 13, which softens the fundamental concern — but does not erase the technical damage.
What the Options Market Says
Dealer positioning frames a $65–$90 corridor as the likely gravitational range around the earnings event. The call wall sits at $90 (open interest: 64,515 contracts), and the put wall is considerably heavier at $65 (open interest: 178,024 contracts) — meaning market makers have a large incentive to defend the $65 level aggressively on any downside move. The asymmetry in open interest leans protective, not speculative.
Pre-earnings call accumulation is concentrated at the $95 strike (+3,267 OI), the $90 strike (+2,981 OI), and the $125 strike (+2,780 OI) — targets that would require a post-earnings pop of 14% to 59% from current levels. Put accumulation is stacked heavily at the $65 strike. The overall options-flow score registers at 70 out of 100, with the signal characterized as accumulation — suggesting that smart money is leaning toward upside positioning even as the stock trades near support.
Despite the bullish options-flow reading, the MACD signal is bearish and the options confidence classification is NEUTRAL-BEARISH with low confidence. The heavy put wall at $65 reflects real hedging activity — institutions are paying to protect against a scenario where a disappointing print sends MXL materially lower. With the stock already down 30% from its peak, a miss could accelerate selling toward that $65 region.
The gamma bias is rated bullish as of October 15, which implies that dealer hedging flows will amplify upside moves (as market makers buy shares to hedge short call exposure) if MXL climbs toward $90. That dynamic could make a beat-and-raise particularly explosive to the upside — but it works in reverse too, and any downside break of $78 loses the gamma support cushion quickly.
Fundamentals & Estimates
The fundamental picture is one of genuine revenue recovery paired with ongoing GAAP losses. Analysts expect Q3 2026 EPS of $0.56 (range: $0.54–$0.57, nine analysts), up from $0.14 in the year-ago quarter — nearly a 4× improvement. Revenue consensus sits at $210.2 million (range: $166.9M–$217.1M), which would represent 66.3% year-over-year growth versus the year-ago quarter's $126.5 million.
Full-year 2026 estimates call for $1.75 EPS and $738 million in revenue (+57.8% YoY), rising to $2.61 EPS and approximately $959 million in revenue in fiscal 2027 as the broadband connectivity and AI-edge upgrade cycle matures. The forward P/E is 31.5× with a notably low PEG ratio of 0.39, indicating the market is not yet pricing in the consensus growth trajectory in full.
Critically, the revision momentum is strongly positive: over the past 30 days, analysts have logged 25 upward EPS revisions and zero downward revisions. The full-year 2026 estimate has climbed from $1.34 ninety days ago to $1.75 today — a 30% upward move in the consensus number. That kind of revision velocity is a meaningful signal that the analyst community has confidence in the near-term trajectory.
The Wall Street consensus price target stands at $94.55 (median: $100.00; high: $125.00; low: $40.00), implying 20% upside from current levels. The ratings breakdown is 7 buys (including 1 strong buy) against 4 holds and zero sells — a constructive but not euphoric stance.
MaxLinear's trailing profit margin is –18.2% and trailing ROE is –21.3%, with an EPS-TTM of –$1.18. The company is not yet consistently profitable on a GAAP basis. If Q3 guidance disappoints — particularly on gross margin progression or the pace of design-win ramp — the forward P/E multiple of 31.5× becomes difficult to defend at current prices.
Key Levels to Watch
| Level | Price | Significance |
|---|---|---|
| Call Wall / Key Resistance | $90.00 | 64,515 contracts OI; reclaiming this level would signal post-earnings recovery |
| 20-Day Resistance | $105.00 | Upper bound of 20-day trendline channel; also near post-catalyst highs |
| 20-Day SMA | $91.69 | Key mean-reversion target; trading below it is a headwind |
| Immediate Support | $78.15 | 20-day trendline support; closing below opens a test of the next level |
| Put Wall / Floor | $65.00 | 178,024 contracts OI; heavy dealer hedging likely to slow declines here |
| 100-Day Support | $56.23 | Long-term structural floor; only relevant in a severe miss scenario |
Bottom Line
MaxLinear heads into its October 22 earnings report with a compelling fundamental setup — 25 analyst upgrades in 30 days, 66% revenue growth expected, and a 0.39 PEG ratio that suggests the stock is under-valued relative to its growth rate — but a technically broken chart. The stock is sitting just above its nearest support at $78.15 after a violent 30% drawdown from the October peak. Options flow suggests accumulation, but the MACD is bearish and confidence is low.
If MXL reports Q3 EPS near the $0.56 consensus and revenue at or above $210 million with upward Q4 guidance, the path to the $90 call wall — and potentially toward the $94.55 analyst target — opens quickly, aided by bullish gamma flows. If it holds $78.15 into the print, the risk/reward skews favorable for a beat scenario. However, any guidance shortfall or gross margin miss from current levels risks a test of $65, where the put wall and dealer hedging create a structural floor. Position sizing should reflect the elevated near-term volatility already visible in the price action.
This article was generated by Tradestie Alpha Assistant using live market data (investment scores, options positioning, trendlines, and fundamentals) and reviewed before publication. It is for informational purposes only and is not financial advice. Do your own research before making investment decisions.